Updates on histiocytic neoplasms and pathological diagnosis in the 5th edition of the WHO Classification of Haematolymphoid Tumours
10.13315/j.cnki.cjcep.2025.08.001
- VernacularTitle:第5版WHO《造血和淋巴组织肿瘤分类》组织细胞肿瘤的更新及病理诊断
- Author:
Hongmei YI
1
;
Chaofu WANG
1
Author Information
1. 上海交通大学医学院附属瑞金医院病理科/上海交通大学医学院病理学系,上海 200025
- Publication Type:Journal Article
- Keywords:
histiocytic neoplasms;
dendritic cell neoplasms;
MAPK signaling pathway;
pathological diagnosis;
differ-ential diagnosis
- From:
Chinese Journal of Clinical and Experimental Pathology
2025;41(8):981-985
- CountryChina
- Language:Chinese
-
Abstract:
The 2022 5th edition WHO Classification of Haematolymphoid Tumours introduces significant revisions to histiocytic and dendritic cell neoplasms,involving the reclassification and renaming of certain diseases alongside the addition of new distinct entities.This article systematically interprets these updates and summarizes the key points for the diagnosis and differential diagnosis of histiocytic neoplasms,aiming to enhance diagnostic accuracy and treatment outcomes for this disease group.
